This article was originally published in The Gray Sheet
Company plans to file a 510(k) for the VeraLook computer-aided detection system for computed tomography (CT) colonography late this month or in April. iCAD previewed the investigational system at the European Society of Radiology annual meeting in Vienna March 6-10. The device can automatically identify polyps and streamline the image reading process, firm says. Data from a National Cancer Institute study published last fall supports using CT colonography, a non-invasive alternative to colonoscopy, as a screening option in cancers 10 mm or larger, but use of the technology may be limited by its cost (1"The Gray Sheet" Sept. 22, 2008, p. 21)
You may also be interested in...
Results of a major study sponsored by the National Cancer Institute and the American College of Radiology Imaging Network provide more support for computed tomographic colonography as an alternative to visual colonoscopy for colorectal cancer screening
China's centralized procurement scheme, if further expanded after causing the prices of 32 drugs to be cut by more than half in the latest round, will leave companies no room to breathe easy amid the already devastating coronavirus outbreak, analysts say.
Sangamo licensed Biogen zinc finger protein transcription factor candidates in an alliance worth over $2bn. Exercising an option it gained in 2017, Takeda bought celiac disease-focused PvP Biologics for up to $330m in earn-outs. A strong showing of IPOs prompted biopharma financing to increase from last month.